Artificial Intelligence-Assisted Drug Discovery for Neurodegenerative Diseases: Integration of Machine Learning, Molecular Docking, and Systems Pharmacology
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) remain among the most therapeutically intractable areas of medicine, with decades of high clinical-trial attrition and an almost complete absence of disease-modifying therapies. Conventional dr...